Literature DB >> 31646127

Metabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV services.

Mohamed H Ahmed1, Clare Woodward2, Dushyant Mital2.   

Abstract

One of the biggest current challenges in managing an ageing cohort living with the HIV is handling dyslipidaemia, diabetes, metabolic syndrome and nonalcoholic fatty liver disease. Combination antiretroviral therapy decrease mortality and morbidity in HIV patients, but lead to increase in insulin resistance, dyslipidaemia, abnormalities of fat distribution and high risk of cardiovascular disease. Therefore, a metabolic clinic was established for individuals living with HIV in the Milton Keynes University Hospital NHS Foundation Trust. The clinic meets considerable demands by service users and hence has the potential to be popular. This review focuses on the importance of the development of a metabolic clinic for the purpose of audit, research, teaching and exchange of knowledge between HIV specialists and the metabolic team in the management of complex cases. Therefore, the metabolic clinic should be an integral part of HIV services especially as the cohort of the 'older' HIV population increases.
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  dyslipidaemia; human immunodeficiency virus; insulin resistance; metabolic clinic

Year:  2017        PMID: 31646127      PMCID: PMC6768511          DOI: 10.1097/XCE.0000000000000128

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol        ISSN: 2162-688X


  40 in total

Review 1.  HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.

Authors:  Wei Zou; Lars Berglund
Journal:  Prev Cardiol       Date:  2007

2.  Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.

Authors:  Bianca M Arendt; Saira S Mohammed; David W L Ma; Elaheh Aghdassi; Irving E Salit; David K H Wong; Maha Guindi; Morris Sherman; E Jenny Heathcote; Johane P Allard
Journal:  Curr HIV Res       Date:  2011-03       Impact factor: 1.581

3.  Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester.

Authors:  J E Mallewa; S P Higgins; S Garbett; N Saxena; F J Vilar
Journal:  Int J STD AIDS       Date:  2009-06       Impact factor: 1.359

4.  Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk?

Authors:  Janet Lo; Steven Grinspoon
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

5.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

6.  Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

Authors:  Bruno Ledergerber; Hansjakob Furrer; Martin Rickenbach; Roger Lehmann; Luigia Elzi; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Matthias Egger; Rainer Weber
Journal:  Clin Infect Dis       Date:  2007-05-21       Impact factor: 9.079

Review 7.  Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.

Authors:  Leonardo Calza; Vincenzo Colangeli; Roberto Manfredi; Isabella Bon; Maria Carla Re; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2016-02-03       Impact factor: 5.790

Review 8.  Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?

Authors:  Mohamed H Ahmed; Salma Barakat; Ahmed O Almobarak
Journal:  J Obes       Date:  2012-12-23

9.  Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Authors:  Signe W Worm; Stephane De Wit; Rainer Weber; Caroline A Sabin; Peter Reiss; Wafaa El-Sadr; Antonella D'Arminio Monforte; Ole Kirk; Eric Fontas; Francois Dabis; Matthew G Law; Jens D Lundgren; Nina Friis-Møller
Journal:  Circulation       Date:  2009-02-02       Impact factor: 39.918

10.  Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection.

Authors:  Takeshi Nishijima; Hiroyuki Gatanaga; Takuro Shimbo; Hirokazu Komatsu; Yuichi Nozaki; Naoyoshi Nagata; Yoshimi Kikuchi; Mikio Yanase; Shinichi Oka
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  4 in total

Review 1.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

Review 2.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

3.  Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease.

Authors:  Mirko Zoncapè; Antonio Liguori; Emmanuel A Tsochatzis
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

4.  Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.

Authors:  Amelia J Davis; Meredith Greene; Eugenia Siegler; Kathleen V Fitch; Sarah A Schmalzle; Alysa Krain; Jaime H Vera; Marta Boffito; Julian Falutz; Kristine M Erlandson
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 20.999

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.